Macromolecular structure for boron neutron-capture therapy
AssigneeThe Regents of the University of California
InventorsRobert R. Kane, M. Frederick Hawthorne
Life of this patent
Estimating the term…
Abstract
A general synthetic method has been developed for the rapid and efficient production of a variety of boron-rich macromolecules suitable for conjugation with of inclusion in receptor-mediated delivery systems as well as other delivery systems. Preparation techniques have been developed to yield precisely ordered oligophosphates which are soluble, hydrophilic, may be homogeneous, and may be prepared with a variety of functional groups.
Claims5
A method of preparing a boron-rich oligophosphate comprising the steps of:
- (i) preparing a dihydroxy carborane derivative;
- (ii) converting said dihydroxy carborane derivative to a mono-hydroxy-protected dihydroxy carborane derivative;
- (iii) reacting said mono-hydroxy-protected dihydroxy carborane derivative with a coupling agent comprising phosphorus to form a protected monomer unit;
- (iv) converting said protected monomer unit to an alcohol by removing the hydroxy-protecting group;
- and,
- (v) reacting at least a plurality of said monomer units to form an oligophosphate.
A method of preparing a boron-rich oligophosphate comprising the steps of:
- (i) forming a carboranyl diol;
- (ii) converting said diol to a mono-hydroxy-protected diol;
- (iii) converting said mono-hydroxy-protected diol to a protected phosphoramidite monomer;
- (iv) converting said protected phosphoramidite monomer to an alcohol by removing the hydroxy-protecting group;
- and,
- (v) reacting at least a plurality of said monomers to form an oligophosphate.
A method for forming a boron-rich oligophosphate comprising the steps of:
- (i) forming an o-carborane diol;
- (ii) converting said o-carborane diol to a mono-hydroxy-protected carboranyl diol;
- (iii) treating said mono-hydroxy-protected carboranyl diol with a phosphate coupling reagent thereby producing a mono-hydroxy-protected phosphotriester;
- (iv) converting the phosphotriester product in step (iii) to an alcohol by removing the hydroxy-protecting group;
- and
- (v) condensing said alcohol product in step (iv) with the mono-hydroxyl-protected diol produced in step (ii) using a phosphate coupling reagent to produce an oligophosphate.
Dependencies are inferred from the claim text.